Grifols, S.A. (GRFS)
Company Info
US3984384087
398438408
May 17, 2006
Highlights
$5.91B
$0.26
27.00
0.23
$5.59B
$2.11B
$1.12B
$5.79 - $9.96
$10.84
0.40%
2.26
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Grifols, S.A., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Grifols, S.A. (GRFS) returned -1.88% year-to-date (YTD) and 6.73% over the past 12 months. Over the past 10 years, GRFS returned -6.27% annually, underperforming the S&P 500 benchmark at 10.43%.
GRFS
-1.88%
12.48%
-23.16%
6.73%
-17.47%
-6.27%
^GSPC (Benchmark)
-3.70%
13.67%
-5.18%
9.18%
14.14%
10.43%
Monthly Returns
The table below presents the monthly returns of GRFS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -7.39% | 22.50% | -15.76% | -2.25% | 5.04% | -1.88% | |||||||
| 2024 | -30.45% | -6.59% | -11.05% | -3.74% | 11.35% | -11.94% | 18.48% | 25.03% | -4.93% | -2.14% | -19.56% | 6.44% | -35.64% |
| 2023 | 7.18% | -4.94% | -14.90% | 1.22% | 10.46% | 11.17% | 19.10% | -13.20% | -3.48% | -11.49% | 19.78% | 19.30% | 36.00% |
| 2022 | 4.54% | 5.28% | -5.50% | -8.13% | 20.04% | -7.76% | -25.25% | -12.50% | -20.72% | 2.44% | 29.16% | 4.29% | -24.31% |
| 2021 | -4.12% | -8.03% | 6.33% | 2.08% | -0.91% | 1.86% | -12.33% | -4.73% | 0.83% | -10.27% | -18.15% | 4.66% | -37.46% |
| 2020 | -2.40% | -5.81% | -5.93% | 0.79% | -6.75% | -3.64% | 3.45% | -15.05% | 8.23% | -0.95% | 9.13% | -0.49% | -19.87% |
| 2019 | 1.42% | 3.54% | 4.30% | -4.82% | -8.10% | 21.09% | 7.87% | -6.41% | -5.92% | 9.33% | 4.43% | 2.79% | 29.31% |
| 2018 | 8.42% | -12.27% | -2.75% | -4.15% | 7.43% | -0.37% | -3.35% | 4.67% | -1.75% | -4.45% | -2.36% | -6.90% | -18.07% |
| 2017 | 5.79% | 2.35% | 8.48% | 15.02% | -0.38% | -1.54% | -0.85% | -1.43% | 6.00% | 8.04% | -3.81% | 1.70% | 45.09% |
| 2016 | -10.37% | 7.44% | -0.83% | 1.62% | 5.15% | 1.82% | 1.62% | -6.08% | 0.38% | -10.52% | 9.38% | 4.14% | 1.45% |
| 2015 | 1.38% | -4.93% | 0.15% | -3.05% | -0.03% | -1.53% | 4.78% | -6.66% | 0.36% | 14.51% | -0.17% | -5.68% | -2.51% |
| 2014 | 9.66% | 6.24% | -1.85% | -0.63% | 1.41% | 6.55% | -16.75% | 9.49% | -12.50% | 0.74% | 5.23% | -7.91% | -4.41% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of GRFS is 54, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Grifols, S.A. (GRFS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Grifols, S.A. provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.00 | $0.00 | $0.00 | $0.00 | $0.46 | $0.20 | $0.39 | $0.48 | $0.38 | $0.35 | $0.35 | $0.30 |
Dividend yield | 0.00% | 0.00% | 0.00% | 0.00% | 4.06% | 1.09% | 1.69% | 2.61% | 1.64% | 2.18% | 2.18% | 1.77% |
Monthly Dividends
The table displays the monthly dividend distributions for Grifols, S.A.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.46 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.46 |
| 2020 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.20 | $0.00 | $0.00 | $0.20 |
| 2019 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.17 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.22 | $0.39 |
| 2018 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.25 | $0.00 | $0.00 | $0.00 | $0.00 | $0.23 | $0.00 | $0.48 |
| 2017 | $0.00 | $0.00 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.21 | $0.38 |
| 2016 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.19 | $0.35 |
| 2015 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.17 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.19 | $0.35 |
| 2014 | $0.14 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.16 | $0.30 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Grifols, S.A.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Grifols, S.A. was 77.82%, occurring on Mar 6, 2024. The portfolio has not yet recovered.
The current Grifols, S.A. drawdown is 70.40%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -77.82% | Feb 24, 2020 | 1016 | Mar 6, 2024 | — | — | — |
| -38.74% | Jul 22, 2011 | 89 | Nov 25, 2011 | 79 | Mar 21, 2012 | 168 |
| -36.89% | Jun 10, 2014 | 413 | Jan 28, 2016 | 352 | Jun 21, 2017 | 765 |
| -28.56% | Jun 13, 2018 | 135 | Dec 24, 2018 | 260 | Jan 7, 2020 | 395 |
| -19.2% | Jan 17, 2018 | 69 | Apr 25, 2018 | 33 | Jun 12, 2018 | 102 |
Volatility
Volatility Chart
The current Grifols, S.A. volatility is 12.44%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Grifols, S.A. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Grifols, S.A., comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -52.7%.
Valuation
The Valuation section provides an overview of how Grifols, S.A. is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for GRFS, comparing it with other companies in the Drug Manufacturers - General industry. Currently, GRFS has a P/E ratio of 27.0. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for GRFS compared to other companies in the Drug Manufacturers - General industry. GRFS currently has a PEG ratio of 0.2. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for GRFS relative to other companies in the Drug Manufacturers - General industry. Currently, GRFS has a P/S ratio of 0.8. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for GRFS in comparison with other companies in the Drug Manufacturers - General industry. Currently, GRFS has a P/B value of 0.8. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |